In-hospital complications associated with total artificial heart implantation in the United States between 2004 to 2011.

IF 1.3 American journal of cardiovascular disease Pub Date : 2022-10-15 eCollection Date: 2022-01-01
Ahmed K Pasha, Justin Z Lee, Hem Desai, Mehrtash Hashemzadeh, Mohammad Reza Movahed
{"title":"In-hospital complications associated with total artificial heart implantation in the United States between 2004 to 2011.","authors":"Ahmed K Pasha,&nbsp;Justin Z Lee,&nbsp;Hem Desai,&nbsp;Mehrtash Hashemzadeh,&nbsp;Mohammad Reza Movahed","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Total artificial heart (TAH) utilization has increased over the recent years. The goal of this study was to evaluate the trend of artificial hearts used in the USA with its associated morbidity and mortality based on a large in-hospital database.</p><p><strong>Materials and methods: </strong>Using a very large nationwide inpatient samples (NIS) database, we used ICD-9 code for a total artificial heart. We evaluated the utilization of this device over the years studied. Furthermore, we evaluated any associated complications and mortality in patients receiving this device.</p><p><strong>Results: </strong>From 2004 until 2011, the rate of total artificial heart implants increased over the years from 5 in 2004 to the highest of 26 in 2011 across the United State. TAH was insesrted in 75 patients. Death was reported in 22 patients (29.3%). Acute renal failure was the most common complication (69.3%). This is followed by post-operative infectious complications (28.0%), acute renal failure requiring dialysis (16%), bleeding complications requiring blood transfusion (14.7%) respiratory complications (6.7%), and stroke/TIA (4.0%). There was no post-operative deep vein thrmobosis or pulmonary embolism.</p><p><strong>Conclusions: </strong>The use of total artificial heart has increased in the United State steadily with substantial morbidity and mortality associated with this device.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2022-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677184/pdf/ajcd0012-0278.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cardiovascular disease","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Total artificial heart (TAH) utilization has increased over the recent years. The goal of this study was to evaluate the trend of artificial hearts used in the USA with its associated morbidity and mortality based on a large in-hospital database.

Materials and methods: Using a very large nationwide inpatient samples (NIS) database, we used ICD-9 code for a total artificial heart. We evaluated the utilization of this device over the years studied. Furthermore, we evaluated any associated complications and mortality in patients receiving this device.

Results: From 2004 until 2011, the rate of total artificial heart implants increased over the years from 5 in 2004 to the highest of 26 in 2011 across the United State. TAH was insesrted in 75 patients. Death was reported in 22 patients (29.3%). Acute renal failure was the most common complication (69.3%). This is followed by post-operative infectious complications (28.0%), acute renal failure requiring dialysis (16%), bleeding complications requiring blood transfusion (14.7%) respiratory complications (6.7%), and stroke/TIA (4.0%). There was no post-operative deep vein thrmobosis or pulmonary embolism.

Conclusions: The use of total artificial heart has increased in the United State steadily with substantial morbidity and mortality associated with this device.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2004年至2011年美国全人工心脏植入相关的住院并发症
目的:近年来全人工心脏(TAH)的使用率有所上升。本研究的目的是基于一个大型医院内数据库,评估美国人工心脏的使用趋势及其相关的发病率和死亡率。材料和方法:使用一个非常大的全国住院患者样本(NIS)数据库,我们使用ICD-9编码进行全人工心脏。我们在研究期间评估了该装置的使用情况。此外,我们评估了接受该装置的患者的任何相关并发症和死亡率。结果:从2004年到2011年,全美人工心脏植入率从2004年的5例逐年上升到2011年最高的26例。75例患者植入TAH。死亡22例(29.3%)。急性肾功能衰竭是最常见的并发症(69.3%)。其次是术后感染并发症(28.0%)、需要透析的急性肾衰竭(16%)、需要输血的出血并发症(14.7%)、呼吸系统并发症(6.7%)和卒中/TIA(4.0%)。术后无深静脉血栓形成或肺栓塞。结论:全人工心脏的使用在美国稳步增加,与该装置相关的发病率和死亡率都很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American journal of cardiovascular disease
American journal of cardiovascular disease CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
21
期刊最新文献
Disparities by sex, race, and region in acute myocardial infarction-related outcomes during the early COVID-19 pandemic: the national inpatient sample analysis. Evaluating antiarrhythmic drugs for managing infants with supraventricular tachycardia; a review. Gender-based disparities in outcomes of coronary bifurcation stenting in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Impact of frailty index on cardiovascular outcomes and readmissions of patent foramen ovale closure procedure: a propensity matched national analysis. Percutaneous coronary intervention involving coronary bifurcation is associated with higher mortality and complications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1